Literature DB >> 17044049

Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach.

Christoph Thorns1, Boris Bastian, Daniel Pinkel, Ritu Roydasgupta, Jane Fridlyand, Hartmut Merz, Manuela Krokowski, Heinz-Wolfram Bernd, Alfred Christian Feller.   

Abstract

Angioimmunoblastic T-cell lymphoma (AILT) is a histopathologically well-defined entity. However, despite a number of cytogenetic studies, the genetic basis of this lymphoma entity is not clear. Moreover, there is an overlap to some cases of peripheral T-cell lymphoma unspecified (PTCL-u) in respect to morphological and genetic features. We used array-based comparative genomic hybridization (CGH) to study genetic imbalances in 39 AILT and 20 PTCL-u. Array-based CGH revealed complex genetic imbalances in both AILT and PTCL-u. Chromosomal imbalances were more frequent in PTCL-u than in AILT and gains exceeded the losses. The most recurrent changes in AILT were gains of 22q, 19, and 11p11-q14 (11q13) and losses of 13q. The most frequent changes in PTCL-u were gains of 17 (17q11-q25), 8 (involving the MYC locus at 8q24), and 22q and losses of 13q and 9 (9p21-q33). Interestingly, gains of 4q (4q28-q31 and 4q34-qtel), 8q24, and 17 were significantly more frequent in PTCL-u than in AILT. The regions 6q (6q16-q22) and 11p11 were predominantly lost in PTCL-u. Moreover, we could identify a recurrent gain of 11q13 in both AILT and PTCL-u, which has previously not been described in AILT. Trisomies 3 and 5, which have been described as typical aberrations in AILT, were identified only in a small number of cases. In conclusion, CGH revealed common genetic events in peripheral T-cell lymphomas as well as peculiar differences between AILT and PTCL-u. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17044049     DOI: 10.1002/gcc.20386

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

Review 1.  Update: peripheral T-cell lymphomas.

Authors:  Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

2.  Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Authors:  Rachael Thomas; Eric L Seiser; Alison Motsinger-Reif; Luke Borst; Victor E Valli; Kathryn Kelley; Steven E Suter; David Argyle; Kristine Burgess; Jerold Bell; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Leuk Lymphoma       Date:  2011-03-07

3.  Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.

Authors:  Staci L Haney; Ryan A Hlady; Jana Opavska; David Klinkebiel; Samuel J Pirruccello; Samikshan Dutta; Kaustubh Datta; Melanie A Simpson; Lizhao Wu; Rene Opavsky
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

4.  Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

Authors:  Javeed Iqbal; George Wright; Chao Wang; Andreas Rosenwald; Randy D Gascoyne; Dennis D Weisenburger; Timothy C Greiner; Lynette Smith; Shuangping Guo; Ryan A Wilcox; Bin Tean Teh; Soon Thye Lim; Soon Yong Tan; Lisa M Rimsza; Elaine S Jaffe; Elias Campo; Antonio Martinez; Jan Delabie; Rita M Braziel; James R Cook; Raymond R Tubbs; German Ott; Eva Geissinger; Philippe Gaulard; Pier Paolo Piccaluga; Stefano A Pileri; Wing Y Au; Shigeo Nakamura; Masao Seto; Francoise Berger; Laurence de Leval; Joseph M Connors; James Armitage; Julie Vose; Wing C Chan; Louis M Staudt
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

5.  Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.

Authors:  S Spinner; G Crispatzu; J-H Yi; E Munkhbaatar; P Mayer; U Höckendorf; N Müller; Z Li; T Schader; H Bendz; S Hartmann; M Yabal; K Pechloff; M Heikenwalder; G L Kelly; A Strasser; C Peschel; M-L Hansmann; J Ruland; U Keller; S Newrzela; M Herling; P J Jost
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

6.  C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas.

Authors:  Rebeca Manso; Carmen Bellas; Paloma Martín-Acosta; Manuela Mollejo; Javier Menárguez; Federico Rojo; Pilar Llamas; Miguel A Piris; Socorro M Rodríguez-Pinilla
Journal:  Haematologica       Date:  2016-05-05       Impact factor: 9.941

Review 7.  Update on the World Health Organization classification of peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

8.  Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Authors:  Tayla B Heavican; Alyssa Bouska; Jiayu Yu; Waseem Lone; Catalina Amador; Qiang Gong; Weiwei Zhang; Yuping Li; Bhavana J Dave; Maarja-Liisa Nairismägi; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Cynthia Lachel; Chao Wang; Kai Fu; Jadd M Stevens; Soon Thye Lim; Choon Kiat Ong; Randy D Gascoyne; Edoardo Missiaglia; Francois Lemonnier; Corinne Haioun; Sylvia Hartmann; Martin Bjerregård Pedersen; Maria Antonella Laginestra; Ryan A Wilcox; Bin Tean Teh; Noriaki Yoshida; Koichi Ohshima; Masao Seto; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Francesco d'Amore; Giorgio Inghirami; Francesco Bertoni; Laurence de Leval; Philippe Gaulard; Louis M Staudt; Timothy W McKeithan; Stefano Pileri; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

9.  Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.

Authors:  M A Laginestra; P P Piccaluga; F Fuligni; M Rossi; C Agostinelli; S Righi; M R Sapienza; G Motta; A Gazzola; C Mannu; E Sabattini; F Bacci; V Tabanelli; C A S Sacchetti; T Z Barrese; M Etebari; F Melle; A Clò; D Gibellini; C Tripodo; G Inghirami; C M Croce; S A Pileri
Journal:  Blood Cancer J       Date:  2014-11-07       Impact factor: 11.037

10.  STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas.

Authors:  Noriaki Yoshida; Shinobu Tsuzuki; Kennosuke Karube; Taishi Takahara; Miyuki Suguro; Hiroaki Miyoshi; Momoko Nishikori; Masanori Shimoyama; Kunihiro Tsukasaki; Koichi Ohshima; Masao Seto
Journal:  Cancer Sci       Date:  2015-08-13       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.